eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


3/2023
vol. 22
 
Share:
Share:
Original paper

Maternal and fetal outcomes after bariatric surgeries

Mohamed M. Farghali
1
,
Fatemah K. Alhadhoud
2
,
Noura H. AlObaidly
2
,
Maryam Mohammad
2
,
Ibrahim A. Abdelazim
1
,
Ainur Amanzholkyzy
3
,
Zaituna Khamidullina
4

  1. Department of Obstetrics and Gynecology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
  2. Department of Obstetrics and Gynecology, Sabah Maternity Hospital, Kuwait
  3. Department of Normal Physiology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
  4. Department of Obstetrics and Gynecology №1, Astana Medical University, Astana, Kazakhstan
Menopause Rev 2023; 22(3): 148-154
Online publish date: 2023/09/25
Article file
- Maternal and fetal.pdf  [0.14 MB]
Get citation
 
PlumX metrics:
 

Introduction

Obesity is a global medical problem, affecting > 650 mil- lion adults all-over the world [1]. Obesity is the most common medical problem affecting reproductive-age women [1]. Maternal obesity, defined as pre-pregnancy body mass index (BMI) ≥ 30 kg/m2 [1].

The Global Health Observatory found the age-standardized prevalence rate of obesity in Kuwait had increased from 18.6% in 1975 to 37.9% in 2016 [2]. A cross-sectional study reported an obesity rate of 36.5, and 44.0% for Kuwaiti men, and women, respectively [3].

Maternal obesity increases the risk of adverse maternal outcome (i.e., gestational diabetes, hypertension, and preeclampsia) [4]. In addition, maternal obesity increases the risk of adverse perinatal outcome (i.e., pre-term, post-term deliveries, large for gestational age (LGA), and perinatal mortality) [5].

Bariatric surgeries (BSs) are the most effective long-term intervention used for reduction of maternal obesity, and for improvement of the pregnancy outcomes (> 50% of BSs performed for reproductive-age women) [6, 7].

The development of gestational diabetes and/or hypertensive disorders with pregnancy are less likely after BSs [8].

The gastric bypass procedures are associated with micronutrients (iron, folic and vitamin D) deficiency [9, 10], compared to laparoscopic sleeve gastrectomy (LSG) or gastric banding [11], which may adversely affect the fetal development [9, 10].

The available guidelines recommend avoiding pregnancy for 1–2 years after BSs [12, 13]. Previous studies have focused on the maternal outcome after BSs, and there is limited available data of perinatal outcome after BSs [5].

Maternal obesity increases the maternal, and fetal obesity-related complications. Bariatric surgeries before pregnancy improves the maternal obesity-related complications but may reduce the absorption of micronutrients needed for fetal development. Therefore, this cross-sectional study designed to detect the prevalence of obesity and BSs in reproductive-age women, and the impact of obesity vs. BSs on the subsequent pregnancy outcomes.

Material and methods

This cross-sectional study was conducted over the year 2019, after approval of the Medical Research Standing Committee (No. 2234/2023), and informed consents following the Helsinki Declaration.

Obese-pregnant women [pre-pregnancy BMI ≥ 30 kg/m2], and women underwent BSs before the current pregnancy, > 20 < 40 years-old, with complete antenatal, and delivery records were included in this study.

Women with incomplete records (i.e., delivery and/or antenatal), spontaneous abortion, twins or triplets, pre-existing medical diseases, gastroesophageal reflux, hiatal hernia, and inflammatory bowel disorders were excluded from this study.

Collected maternal data include maternal age, parity, pre-pregnancy BMI, BSs type, BS-to-conception interval, medical disorders with pregnancy [i.e., gestational diabetes mellitus (GDM), and preeclampsia (PE)], mode of delivery [cesarean sections (CSs) or vaginal].

Collected fetal data include gestational age at delivery [i.e., full term (> 37–40 weeks) or preterm delivery (PTD < 37 weeks)], fetal birth weight [normal, small for gestational age (SGA), or LGA], and adverse fetal outcome [intrauterine growth retardation (IUGR), low Apgar score (< 7) at 5 min., and neonatal intensive care unit (NICU) admission].

The participants` weight, and height were used to calculate their BMI (kg/m2). The World Health Organization considered ≤ 24.9 kg/m2 (normal weight), 25.0–29.9 kg/m2 (overweight), 30–34.9 (obesity class I), 35.0–39.9 (obesity class II), and ≥ 40 kg/m2 (obesity class III) [14].

The bariatric surgeries classified into; malabsorptive surgeries (i.e., Roux-en-Y gastric bypass) which associated with micronutrients (i.e., iron, folic and vitamin D) deficiency [9, 10], and restrictive surgeries [i.e., LSG and laparoscopic gastric banding (LGB)] which reduce the stomach capacity] [11].

Gestational diabetes mellitus is glucose intolerance occurs during pregnancy and diagnosed by the OGTT at 24–28 weeks` [15].

PE is hypertension (blood pressure ≥ 140/90 mm Hg measured twice over ≥ 4-hrs.), and proteinuria after 20 weeks` without history of hypertension [1618]. The proteinuria is ≥ 300 mg proteins/24-hrs. urine and/or protein/creatinine ratio ≥ 0.3 [16, 19].

The normal fetal birth weight at term pregnancy (> 37–40 weeks) is > 2.5–4 kg [20]. Fetal birth weight < 10th percentile at term pregnancy was considered SGA, and fetal birth weight > 90th percentile was considered LGA irrespective the gestational age at delivery [21].

Weight-for-age percentiles were calculated using the Dutch Perined-birth weight charts, stratified for sex and gestational age at delivery in days [22].

Intrauterine growth retardation is an intrauterine fetal growth less than the normal potential growth as per the fetal race and gender [23].

Collected data analyzed to detect the prevalence of obesity and BSs in reproductive-age women (primary outcome), and the impact of obesity vs. BSs on the subsequent pregnancy outcomes (secondary outcome).

Statistical analysis

The sample size was calculated using data from a previous study [24], and G Power software. The collected data were analyzed using the t-test (for quantitative data), and the χ2 test (for qualitative data). The MedCalc 20.106 (MedCalc Ltd, Belgium) was used to calculate the odd ratio (OR), and relative risk (RR) of adverse maternal and fetal outcomes in relation to maternal obesity vs. BSs. P < 0.05 considered significant.

Declaration of consent

The current study was conducted after approval of the Medical Research Standing Committee (No. 2234/2023), and after informed consent.

Results

During this cross-sectional study, data of 14,474 pregnant women collected; 33.94% (4912/14474) of them were obese (pre-pregnant BMI ≥ 30 kg/m2), and 3.8% (546/14474) of them had previous BSs before the current pregnancy.

Characteristics of obese-pregnant women (obese group) vs. pregnant women underwent BSs before the current pregnancy (BSs group) were presented in Table 1.

Table 1

Characteristics, maternal and fetal outcomes of obese-pregnant group versus BS-pregnant group

ParametersObese group, N = 4912 (%)BS group, N = 546 (%)p-value (95% CI)
Maternal age (years)28.2 ±2.431.3 ±2.60.9 (–3.3, –3.1, –2.9)
Parity3.2 ±1.72.6 ±1.80.9 (0.4, 0.6, 0.77)
Pre-pregnancy BMI [kg/m2]32.5 ±3.526.8 ±3.10.0001* (5.4, 5.7, 5.9)
Pre-pregnancy infertility1418 (28.9)112 (20.5)0.001*
Type of BSs
Gastric bypass55 (10.1)
LSG444 (81.3)
LGB47 (8.6)
BS- to-conception interval
< 12 months163 (29.9)
12–24 months247 (45.2)
> 24 months136 (24.9)
Gestational diabetes692 (14.1)43 (7.9)0.0003*
Gestational hypertension831 (16.9)58 (10.6)0.001*
Preeclampsia912 (18.6)63 (11.5)0.0005*
Mode of delivery
Vaginal deliveries3621 (73.7)431 (78.9)0.3
Cesarean sections1291 (26.3)115 (21.1)0.03*
Large for gestational age732 (14.9)61 (11.2)0.03*
Gestational age at delivery
Term deliveries4380 (89.2)490 (89.7)1.0
Preterm deliveries532 (10.8)56 (10.3)0.7
Small for gestational573 (11.7)51 (9.3)0.1
IUGR504 (10.3)45 (8.2)0.1
Low Apgar score at 5 min. (< 7)25 (0.5)6 (1.1)0.1
NICU admission136 (2.8)14 (2.6)0.7

[i] BMI – body mass index, BSs – bariatric surgery, CI – confidence interval, IUGR – intrauterine growth retardation, LGB – laparoscopic gastric banding, LSG – laparoscopic sleeve gastrectomy, NICU – neonatal intensive care unit

[ii] χ2 test used for statistical analysis when data presented as number and percentage (%).

[iii] Data presented as mean and standard deviation (SD) and number (n) and percentage (%).

[iv] Student t-test used for statistical analysis when data presented as mean ± SD.

The obese group, and the BSs group were matched with no significant difference regarding the maternal age (28.2 ±2.4 vs. 31.3 ±2.6 years, respectively), (p = 0.9), and parity (3.2 ±1.7 vs. 2.6 ±1.8, respectively), (p = 0.9). The pre-pregnancy BMI was significantly higher in the obese group compared to BSs group to (32.5 ±3.5 vs. 26.8 ±3.1 kg/m2, respectively), (p = 0.0001), and the number of women with pre-pregnancy infertility was significantly higher in the obese group compared to BSs group [28.9% (1418/4912) vs. 20.5% (112/546), respectively] (p = 0.001) (Table 1).

Most women in the BSs group underwent LSG (81.3%), while 10.1% of them underwent Gastric bypass, and 8.6% underwent LGB.

Although, the guidelines recommend avoiding pregnancy for 12–24 months after BSs, 45.2% of the studied women in the BSs group had 12–24 months BS-to- conception interval, 29.9% had < 12 months BS-to- conception interval, and 24.9% had > 24 months BS-to-conception interval (Table 1).

Maternal outcome

The incidence of GDM, gestational hypertension, and PE was significantly higher in the obese group (14.1%, 16.9% and 18.6%, respectively) compared to BSs group (7.9%, 10.6% and 11.5%, respectively), (p = 0.0003, 0.001 and 0.0005, respectively). The incidence of CSs was also significantly higher in the obese group (26.3%) compared to BS group (21.1%), (p = 0.03) (Table 1).

Fetal outcome

The incidence of LGA was significantly higher in the obese group (14.9%) compared to BSs group (11.2%), (p = 0.03).

There was no significant difference between the obese group, and BSs group regarding, the incidence of PTD (10.8% vs. 10.3%, respectively), (p = 0.7), SGA (11.7% vs. 9.3%, respectively), (p = 0.1), and IUGR (10.3% vs. 8.2%, respectively), (p = 0.1). There was also no significant difference between the obese group, and BSs group regarding, the incidence of low Apgar score at 5 min. (0.5% vs. 1.1%, respectively), (p = 0.1), and NICU admission (2.8% vs. 2.6%, respectively), (p = 0.7) (Table 1).

The odds and risks of adverse outcomes

The obese group has significantly higher odds, and risks of GDM [OR 1.9 (p = 0.0001), and RR 1.79 (p = 0.0001)], gestational hypertension [OR 1.7 (p = 0.0002), and RR 1.6 (p = 0.0003)], and PE [OR 1.7 (p = 0.0001), and RR 1.6 (p = 0.0001)] compared to BSs group. The obese group has also significantly higher odds, and risks of CSs [OR 1.3 (p = 0.008), and RR 1.25 (p = 0.01)], and LGA [OR 1.39 (p = 0.01), and RR 1.3 (p = 0.02)] compared to BSs group (Table 2).

Table 2

The odd ratios, and relative risks of adverse maternal and fetal outcomes in the two-studied groups

ParametersObese group, N = 4912BS group, N = 546OR [p-value (95% CI)]
RR [p-value (95% CI)]
Gestational diabetes
Positive692431.9 [p = 0.0001* (95% CI: 1.4–2.65)]
Negative42205031.79 [p = 0.0001* (95% CI: 1.3–2.4)]
Gestational hypertension
Positive831581.7 [p = 0.0002* (95% CI: 1.3–2.3)]
Negative40814881.6 [p = 0.0003* (95% CI: 1.2–2.05]
Preeclampsia
Positive912631.7 [p = 0.0001* (95% CI: 1.3–2.3)]
Negative40004831.6 [p = 0.0001* (95% CI: 1.27–2.04)]
Cesarean sections
Positive12911151.3 [p = 0.008* (95% CI: 1.08–1.65)]
Negative36214311.25 [p = 0.01* (95% CI: 1.05–1.48)]
Large for gestational age
Positive732611.39 [p = 0.01* (95% CI: 1.05–1.8)]
Negative41804851.3 [p = 0.02* (95% CI: 1.04–1.7)]
Preterm deliveries
Positive532561.06 [p = 0.6 (95% CI: 0.8–1.4)]
Negative43804901.06 [p = 0.7 (95% CI: 0.8–1.4)]
Small for gestational
Positive573511.28 [p = 0.1 (95% CI: 0.95–1.7)]
Negative43394951.25 [p = 0.1 (95% CI: 0.95–1.6)]
IUGR
Positive504451.27 [p = 0.1 (95% CI: 0.93–1.8)]
Negative44085011.25 [p = 0.1 (95% CI: 0.93–1.6)]
Low Apgar score at 5 min. (< 7)
Positive2560.46 [p = 0.08 (95% CI: 0.19–1.13)]
Negative48875400.46 [p = 0.08 (95% CI: 0.19–1.12)]
NICU admission
Positive136141.08 [p = 0.7 (95% CI: 0.62–1.89)]
Negative47765321.07 [p = 0.7 (95% CI: 0.63–1.9)]

[i] BSs – bariatric surgery, CI – confidence interval, IUGR – intrauterine growth retardation, NICU – neonatal intensive care unit, ORs – odd ratios, RRs – relative risks

The odds, and risks of PTD [OR 1.06 (p = 0.6), and RR 1.06 (p = 0.7)], SGA [OR 1.28 (p = 0.1), and RR 1.25 (p = 0.1)], and IUGR [OR 1.27 (p = 0.1), and RR 1.25 (p = 0.1)] were statistically insignificant between the two-studied groups. The odds, and risks of low Apgar score at 5 min. [OR 0.46 (p = 0.08), and RR 0.46 (p = 0.08)], and NICU admission [OR 1.08 (p = 0.7), and RR 1.07 (p = 0.7)] were also statistically insignificant between the two-studied groups (Table 2).

Discussion

Data of 14,474 pregnant women were collected for this cross-sectional study to detect the prevalence of obesity and BSs in reproductive-age women, and the impact of obesity vs. BSs on the subsequent pregnancy outcomes. About 33.94% (4912/14474) of the studied-pregnant women were obese, and 3.8% (546/14474) of them had previous BSs before the current pregnancy.

Kuwait is ranked as one of the top countries in obesity [3]. A cross-sectional population-based survey found the obesity was relatively greater in Kuwaiti-women (47.9%) compared to men (38.5%) [2]. The genetic susceptibility, high-caloric diet, and cultural barriers to physical activity can explain the prevalence of obesity in the Gulf countries [3].

The number of women with pre-pregnancy infertility was significantly higher in the obese group compared to BSs group (28.9% vs. 20.5%, respectively), (p = 0.001). Obesity decreases the reproductive ability through insulin resistance, which adversely affects the ovarian follicle growth and maturation, with subsequent oligo- amenorrhea, and hyperandrogenemia [25]. Obesity associated with impaired ART treatment outcome (i.e., decreased oocyte number, and quality) [25], and a meta-analysis reported 58% spontaneous conception rate after BSs [26].

Maternal outcome

The incidence of GDM, gestational hypertension, and PE in this study was significantly higher in the obese group (14.1%, 16.9% and 18.6%, respectively) compared to BSs group (7.9%, 10.6% and 11.5%, respectively), (p = 0.0003, 0.001 and 0.0005, respectively). The obese group has significantly higher odds, and risks of GDM [OR 1.9 (p = 0.0001), and RR 1.79 (p = 0.0001)], gestational hypertension [OR 1.7 (p = 0.0002), and RR 1.6 (p = 0.0003)], and PE [OR 1.7 (p = 0.0001), and RR 1.6 (p = 0.0001)] compared to BSs group.

Similarly, a prospective study found the incidence of pregnancy-induced hypertension, and GDM (38% and 19%, respectively) were significantly higher in obese cohort compared to controls (10% and 6.3%, respectively) [27]. An observational study also found the incidence of GDM, and hypertension was significantly less after LGB [28].

Moreover, a case-control study, reported significantly lower rates of gestational hypertension (9.6% vs. 23.5%, respectively), PE/eclampsia (12.0% vs. 20.8%, respecti- vely), and CSs (45.9% vs. 65.8%, respectively) after LGB compared to obese controls [29].

The incidence of CSs in this study was significantly higher in the obese group (26.3%) compared to BSs group (21.1%), (p = 0.03), and the obese group has significantly higher odds, and risks of CSs [OR 1.3 (p = 0.008), and RR 1.25 (p = 0.01)] compared to BSs group.

An observational, descriptive study found maternal obesity increases the risk of CSs, [30], and a historical study found obese women had a higher risk of CSs compared to controls [31]. A retrospective analysis of 287,213 singleton pregnancies, found the rate of emergency CSs was significantly higher in obese women compared to controls [32]. Rottenstreich et al., reported a lower CSs rate after LGS [33], and a meta-analysis reported decreased CSs rate after BSs [34].

Moreover, Giannini et al. [35] studied the surgically treated women with endometrial cancers in a retrospective-observational study to evaluate the effect of obesity, comorbidities, and fragility, on the postoperative (PO) complications after surgery for endometrial cancer. The fragility was evaluated using the modified fragility index (mFI) calculated from the number of the comorbidities in each studied woman [35]. Women with class III obesity (BMI ≥ 40) were more likely to have mFI > 3. At multivariate analysis Giannini et al. [35] found laparotomy, and mFI > 3 were independent predictors of overall PO complications. At univariate analysis, Giannini et al. [35] found BMI ≥ 40, smoking, and mFI > 3 were significant predictors of severe PO complications.

Recently, A recent narrative review (including 85957 women) was conducted by Ottavia et al. [36] to highlight the importance of the peri-operative frailty assessment in women with gynecological cancer, and to discuss the commonly used scores to predict the adverse PO outcomes, and overall survival.

Ottavia et al. [36], found the mFI was the commonly used tool for perioperative definition of frail women. They also found frail women had lower disease-free survival rates, lower overall survival rates, and had higher risk of developing 30-day PO complications, non-home discharge, and ICU admission than non-frail women [36].

Fetal outcome

The incidence of LGA in this study was significantly higher in the obese group (14.9%) compared to BSs group (11.2%), (p = 0.03), and the obese group has significantly higher odds, and risks of LGA [OR 1.39 (p = 0.01), and RR 1.3 (p = 0.02)] compared to BSs group.

Similarly, a prospective cross-sectional study found a significant portion of obese mothers had LGA babies [37], another study found the obese women had a higher risk of LGA compared to controls [31]. A retrospective analysis of 287,213 singleton pregnancies, found the LGA rate, was significantly higher in obese pregnant women compared to controls [32]. Moreover, a meta-analysis found a significant reduction in the incidence of LGA, and macrosomia after BSs [34], and a systematic review reported decreased odds of LGA after gastric bypass [5].

Although an observational, descriptive study found maternal obesity increases the risk of PTD [30]. A historical study found the maternal obesity was not associated with PTD [31], and a meta-analysis found the incidence of PTD was similar after BSs compared to controls [34]. This study also found no significant difference between the two-studied groups regarding the incidence of PTD (10.8% for the obese group vs. 10.3% for the BSs group), (p = 0.7).

Although Rottenstreich et al, found the LSG was associated with increased risk of SGA [33], and a population- based study reported increased risk of IUGR after BSs [38].

A retrospective controlled study found the incidence of LBW was less after LBG compared to malabsorptive bypass procedure [39]. In addition, Goldman et al., found the fetal birth weight was significantly lower after malabsorptive gastric bypass procedure but not after LGB [40].

This study also found no significant difference between the two-studied groups regarding the incidence of SGA (11.7% for the obese group vs. 9.3% for the BSs group), (p = 0.1), and IUGR (10.3% for the obese group vs. 8.2% for the BS-surgery group), (p = 0.1).

A Danish study reported increased risk of SGA after malabsorptive BSs [41], and a single-center study repor- ted increased risk of IUGR after malabsorptive BSs [42].

Gascoin et al., found an inverse relation between the fetal birth weight, and maternal weight loss after BSs (the greater maternal weight loss after BSs, the lower the fetal birth weight) [9]. The finding explains the birth weight difference between women delivered after LGB or LGS compared to women delivered after malabsorptive bypass [9].

Although a meta-analysis reported increased odds of NICU admission after BSs [5]. This study found no significant difference between the two-studied groups regarding the low Apgar score at 5 min. (0.5% for the obese group vs. 1.1% for the BSs group), (p = 0.1), and NICU admission (2.8% for the obese group vs. 2.6% for the BSs group), (p = 0.7). A retrospective cohort study also found the 5-min Apgar scores, and NICU admissions, were similar with no significant difference in the gastric bypass group compared to controls [43]. In addition, a matched-control study found the neonatal complications were similar with no significant difference after gastric bypass compared to controls [44]. The inconsistent results regarding the low Apgar score at 5 min., and NICU admission may be explained by the BS-to-birth interval. BS-to-birth intervals < 2 years was associated with higher risks of neonatal complications, and NICU admission compared with longer intervals [45]. The inconsistent results regarding the low Apgar score at 5 min. and NICU admission after BSs need further studies.

This study found 33.94% of the reproductive-age women in Kuwait are obese, and 3.8% of them had previous BSs (LSG is the commonest BSs procedure done in Kuwait). Although, the guidelines recommend avoiding pregnancy for 12–24 months after BSs, 45.2% of studied women in the BSs group had 12–24 months BS-to-conception interval, and 29.9% had < 12 months BS-to-conception interval.

Obese-pregnant women are at increased risks of GDM, gestational hypertension, PE, and CSs. The BSs reduced the rates of GDM, gestational hypertension, PE and CSs significantly. Obesity, and BSs did not increase the rate of neonatal complications including, prematurity, SGA, IUGR, low Apgar score at 5 min., and NICU admission.

This study was the first, cross-sectional study conducted in Kuwait, including 14,474 pregnant-women to detect the prevalence of obesity and BSs in reproductive-age women, and the impact of obesity vs. BSs on the subsequent pregnancy outcomes.

Women refused to participate, failure to identify causes of NICU admission, and neonatal outcome after NICU admission were the limitations of this study.

Conclusions

About 33.94% of the reproductive-age women in Kuwait are obese, and 3.8% of them had previous BSs (LSG is the commonest BSs procedure done in Kuwait). Obese-pregnant women are at increased risks of GDM, gestational hypertension, PE and CSs. Bariatric surgeries reduced the rates of GDM, gestational hypertension, PE and CSs significantly.

Disclosure

The authors report no conflict of interest.

References

1 

Catalano PM, Shankar K. Obesity, and pregnancy: mechanisms of short term and long-term adverse consequences for mother and child. BMJ 2017; 356: j1.

2 

Oguoma VM, Coffee NT, Alsharrah S, et al. Prevalence of overweight and obesity, and associations with socio-demographic factors in Kuwait. BMC Public Health 2021; 21: 667.

3 

Weiderpass E, Botteri E, Longenecker JC, et al. The prevalence of overweight and obesity in an adult Kuwaiti population in 2014. Front Endocrinol (Lausanne) 2019; 10: 449.

4 

Marchi J, Berg M, Dencker A, Olander EK, Begley C. Risks associated with obesity in pregnancy, for the mother and baby: a systematic review of reviews. Obes Rev 2015; 16: 621-38.

5 

Akhter Z, Rankin J, Ceulemans D, et al. Pregnancy after bariatric surgery and adverse perinatal outcomes: a systematic review and meta-analysis. PLoS Med 2019; 16: e1002866.

6 

Godfrey KM, Reynolds RM, Prescott SL, et al. Influence of maternal obesity on the long-term health of offspring. Lancet Diabetes Endocrinol 2017; 5: 53-64.

7 

Øvrebø B, Strømmen M, Kulseng B, Martins C. Bariatric surgery versus lifestyle interventions for severe obesity: 5-year changes in body weight, risk factors and comorbidities. Clin Obes 2017; 7: 183-190.

8 

Yi XY, Li QF, Zhang J, Wang ZH. A meta-analysis of maternal and fetal outcomes of pregnancy after bariatric surgery. Int J Gynaecol Obstet 2015; 130: 3-9.

9 

Gascoin G, Gerard M, Sallé A, et al. Risk of low birth weight and micronutrient deficiencies in neonates from mothers after gastric bypass: a case control study. Surg Obes Relat Dis 2017; 13: 1384-1391.

10 

Stephenson J, Heslehurst N, Hall J, et al. Before the beginning: nutrition and lifestyle in the preconception period and its importance for future health. Lancet 2018; 391: 1830-1841.

11 

O’Kane M, Parretti HM, Pinkney J, et al. British Obesity and Metabolic Surgery Society Guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery–2020 update. Obes Rev 2020; 21: e13087.

12 

Heusschen L, Krabbendam I, van der Velde JM, et al. A matter of timing-pregnancy after bariatric surgery. Obes Surg 2021; 31: 2072-2079.

13 

Shekelle PG, Newberry S, Maglione M, et al. Bariatric surgery in women of reproductive age: special concerns for pregnancy. Evid Rep Technol Assess (Full Rep) 2008; (169): 1-51.

14 

Abdelazim IA, Amer OO, Farghali M. Common endocrine disorders associated with the polycystic ovary syndrome. Prz Menopauz 2020; 19: 179-183.

15 

American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33: S62-69.

16 

Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol 2013; 122: 1122-1131.

17 

Hagras AM, Abdelazim IA, Elhamamy N. The accuracy of the calcium-creatinine ratio in a spot urine sample for predicting preeclampsia. Prz Menopauz 2022; 21: 191-196.

18 

Farghali M, Abdelazim I, Abdelrazek K. Delayed second twin delivery: benefits and risks. J Matern Fetal Neonatal Med 2019; 32: 1626-1632.

19 

Abdelazim IA, Amer OO, Shikanova S, Karimova B. Protein/creatinine ratio versus 24-hours urine protein in preeclampsia. Ginekol Pol 2022; 93: 975-979.

20 

Cutland CL, Lackritz EM, Mallett-Moore T, et al. Low birth weight: case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine 2017; 35: 6492-6500.

21 

Macrosomia: ACOG Practice Bulletin, Number 216. Obstet Gynecol 2020; 135: e18-e35.

22 

Salavati N, Bakker MK, van der Beek EM, Erwich JHM. Cohort profile: the Dutch perined-lifelines birth cohort. PLoS One 2019; 14: e0225973.

23 

Abdelazim IA, Abu-Faza M, Hamed MES, Amer OO, Shikanova S, Zhurabekova G. Prenatal diagnosis of single umbilical artery complicated by intrauterine growth retardation and preterm labor: case report. J Family Med Prim Care 2019; 8: 2151-2154.

24 

Khalifa E, El-Sateh A, Zeeneldin M, et al. Effect of maternal BMI on labor outcomes in primigravida pregnant women. BMC Pregnancy Childbirth 2021; 21: 753.

25 

Falcone V, Stopp T, Feichtinger M, et al. Pregnancy after bariatric surgery: a narrative literature review and discussion of impact on pregnancy management and outcome. BMC Pregnancy Childbirth 2018; 18: 507.

26 

Milone M, De Placido G, Musella M, et al. Incidence of successful pregnancy after weight loss interventions in infertile women: a systematic review and meta-analysis of the literature. Obes Surg 2016; 26: 443-451.

27 

Dixon JB, Dixon ME, O’Brien PE. Birth outcomes in obese women after laparoscopic adjustable gastric banding. Obstet Gynecol 2005; 106: 965-972.

28 

Skull AJ, Slater GH, Duncombe JE, Fielding GA. Laparoscopic adjustable banding in pregnancy: safety, patient tolerance and effect on obesity-related pregnancy outcomes. Obes Surg 2004; 14: 230-235.

29 

Lapolla A, Marangon M, Dalfrà MG, et al. Pregnancy outcome in morbidly obese women before and after laparoscopic gastric banding. Obes Surg 2010; 20: 1251-1257.

30 

Indarti J, Susilo SA, Hyawicaksono P, Berguna JSN, Tyagitha GA, Ikhsan M. Maternal and perinatal outcome of maternal obesity at RSCM in 2014–2019. Obstet Gynecol Int 2021; 2021: 6039565.

31 

Melchor I, Burgos J, Del Campo A, Aiartzaguena A, Gutiérrez J, Melchor JC. Effect of maternal obesity on pregnancy outcomes in women delivering singleton babies: a historical cohort study. J Perinat Med 2019; 47: 625-630.

32 

Sebire NJ, Jolly M, Harris JP, et al. Maternal obesity, and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord 2001; 25: 1175-1182.

33 

Rottenstreich A, Elchalal U, Kleinstern G, Beglaibter N, Khalaileh A, Elazary R. Maternal and perinatal outcomes after laparoscopic sleeve gastrectomy. Obstet Gynecol 2018; 131: 451-456.

34 

Young B, Drew S, Ibikunle C, Sanni A. Maternal and fetal delivery outcomes in pregnancies following bariatric surgery: a meta-analysis of the literature. Mini-invasive Surg 2018; 2: 16.

35 

Giannini A, Di Donato V, Schiavi MC, May J, Panici PB, Congiu MA. Predictors of postoperative overall and severe complications after surgical treatment for endometrial cancer: the role of the fragility index. Int J Gynaecol Obstet 2020; 148: 174-180.

36 

D’Oria O, Golia D’Auge T, Baiocco E, et al. The role of preoperative frailty assessment in patients affected by gynecological cancer: a narrative review. Ital J Gynecol Obstet 2022; 34: 76-83.

37 

Vernini JM, Moreli JB, Magalhães CG, Costa RAA, Rudge MVC, Calderon IMP. Maternal and fetal outcomes in pregnancies complicated by overweight and obesity. Reprod Health 2016; 13: 100.

38 

Parker MH, Berghella V, Nijjar JB. Bariatric surgery and associated adverse pregnancy outcomes among obese women. J Matern Fetal Neonatal Med 2016; 29: 1747-1750.

39 

Ducarme G, Revaux A, Rodrigues A, Aissaoui F, Pharisien I, Uzan M. Obstetric outcome following laparoscopic adjustable gastric banding. Int J Gynaecol Obstet 2007; 98: 244-247.

40 

Goldman RH, Missmer SA, Robinson MK, Farland LV, Ginsburg ES. Reproductive outcomes differ following Roux-en-Y gastric bypass and adjustable gastric band compared with those of an obese non-surgical group. Obes Surg 2016; 26: 2581-2589.

41 

Hammeken LH, Betsagoo R, Jensen AN, Sørensen AN, Overgaard C. Nutrient deficiency and obstetrical outcomes in pregnant women following Roux-en-Y gastric bypass: a retrospective Danish cohort study with a matched comparison group. Eur J Obstet Gynecol Reprod Biol 2017; 216: 56-60.

42 

Chevrot A, Kayem G, Coupaye M, Lesage N, Msika S, Mandelbrot L. Impact of bariatric surgery on fetal growth restriction: experience of a perinatal and bariatric surgery center. Am J Obstet Gynecol 2016; 214: 655.e1-7.

43 

Wax JR, Cartin A, Wolff R, Lepich S, Pinette MG, Blackstone J. Pregnancy following gastric bypass for morbid obesity: effect of surgery-to-conception interval on maternal and neonatal outcomes. Obes Surg 2008; 18: 1517-1521.

44 

Adams TD, Hammoud AO, Davidson LE, et al. Maternal and neonatal outcomes for pregnancies before and after gastric bypass surgery. Int J Obes (Lond) 2015; 39: 686-694.

45 

Parent B, Martopullo I, Weiss NS, Khandelwal S, Fay EE, Rowhani-Rahbar A. Bariatric surgery in women of childbearing age, timing between an operation and birth, and associated perinatal complications. JAMA Surg 2017; 152: 128-135.

Copyright: © 2023 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.